These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20574626)

  • 41. The uselessness of procalcitonin in the diagnosis of focal bacterial central nervous system infection.
    Hoshina T; Takimoto T; Nanishi E; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2015 Aug; 21(8):620-2. PubMed ID: 25971424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Will procalcitonin reduce antibiotic use in intensive care?
    Kollef MH
    Lancet; 2010 Feb; 375(9713):435-6. PubMed ID: 20097416
    [No Abstract]   [Full Text] [Related]  

  • 43. Procalcitonin may help differentiate disseminated herpes simplex viral infection from bacterial sepsis in neonates.
    Hatherill M; Sykes K; McIntyre AG; Murdoch IA
    Eur J Pediatr; 2000 Mar; 159(3):168-9. PubMed ID: 10664229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Stannard D
    Crit Care Nurse; 2014 Apr; 34(2):75-6. PubMed ID: 24692469
    [No Abstract]   [Full Text] [Related]  

  • 45. Procalcitonin-based guidelines and lower respiratory tract infections.
    Cals JW; Metlay JP
    JAMA; 2010 Feb; 303(5):418; author reply 419-20. PubMed ID: 20124534
    [No Abstract]   [Full Text] [Related]  

  • 46. Septic shock with methicillin-sensitive Staphylococcus aureus secondary to continuous subcutaneous insulin infusion by external pump.
    Ben Hamou A; Maurou O; Nadler S; Dupuy O
    Diabetes Metab; 2021 Mar; 47(2):101165. PubMed ID: 32461155
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical biomarker procalcitonin (PCT) and its effect on antibiotic usage.
    Kappes J
    S D Med; 2010 May; 63(5):178-9. PubMed ID: 20462063
    [No Abstract]   [Full Text] [Related]  

  • 49. Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritis.
    De Bels D; Garcia-Filoso A; Jeanmaire M; Préseau T; Miendje Deyi VY; Devriendt J
    J Antimicrob Chemother; 2005 May; 55(5):812-3. PubMed ID: 15743893
    [No Abstract]   [Full Text] [Related]  

  • 50. Procalcitonin: a bacterial specific marker of infection.
    George A; Coulson C; De R
    Clin Otolaryngol; 2007 Aug; 32(4):310. PubMed ID: 17651293
    [No Abstract]   [Full Text] [Related]  

  • 51. [Procalcitonin as a marker for severe sepsis in an immunosuppressed patient].
    Axer H; Wohlfarth M; Meisner M; Finn S; Ragoschke-Schumm A; Mentzel HJ; Witte OW; Isenmann S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Feb; 40(2):97-102. PubMed ID: 15714400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study.
    Rau BM; Frigerio I; Büchler MW; Wegscheider K; Bassi C; Puolakkainen PA; Beger HG; Schilling MK
    Arch Surg; 2007 Feb; 142(2):134-42. PubMed ID: 17309964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock.
    Zelenitsky S; Rubinstein E; Ariano R; Iacovides H; Dodek P; Mirzanejad Y; Kumar A;
    Int J Antimicrob Agents; 2013 Mar; 41(3):255-60. PubMed ID: 23312606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recognizing, understanding, and treating critical community acquired methicillin-resistant Staphylococcus aureus infection in children.
    Carcillo JA; Castillo L; Thomas J; Kissoon N
    Pediatr Crit Care Med; 2009 May; 10(3):405-7. PubMed ID: 19433946
    [No Abstract]   [Full Text] [Related]  

  • 55. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
    Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
    [No Abstract]   [Full Text] [Related]  

  • 56. The toxic shock syndrome.
    Shepherd JH
    Br J Hosp Med; 1982 Sep; 28(3):234-6. PubMed ID: 7126986
    [No Abstract]   [Full Text] [Related]  

  • 57. [Infection and plasma procalcitonin].
    Yukioka H
    Clin Calcium; 2005 Mar; 15(3):152-7. PubMed ID: 15741695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trials of biomarker-guided antimicrobial therapy in sepsis: improvements in trial design require better control groups.
    Salluh JI; Póvoa P
    Crit Care Med; 2014 Feb; 42(2):e172. PubMed ID: 24434473
    [No Abstract]   [Full Text] [Related]  

  • 59. Procalcitonin in diagnosis of severe infections.
    Al-Nawas B; Krammer I; Shah PM
    Eur J Med Res; 1996 Apr; 1(7):331-3. PubMed ID: 9364034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early recognition and treatment of staphylococcal and streptococcal toxic shock.
    Nelson C
    J Pediatr Adolesc Gynecol; 2004 Aug; 17(4):289-92. PubMed ID: 15288032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.